CG Oncology, Inc. - Common stock (NQ:CGON)

68.71 +1.33 (+1.97%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CG Oncology, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗

December 03, 2025

One fast-growing digital health stock just secured a notable new backer—right as its financial momentum hits a fresh gear.

Via The Motley Fool

Topics Initial Public Offering Regulatory Compliance

Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗

December 03, 2025

One fund is quietly buying into ACADIA — just as the company posts one of its strongest quarters in years.

Via The Motley Fool

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗

December 03, 2025

Soleno just turned profitable for the first time—right as a major fund made its move.

Via The Motley Fool

Topics Regulatory Compliance

CG Oncology Announces New Board Member and Board Transition

November 26, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting

November 25, 2025

Two late-breaking podium presentations and three posters continue to demonstrate cretostimogene as a potential backbone therapy for a broad range of NMIBC patients

From CG Oncology Inc.

Via GlobeNewswire

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

A science-first biotech fund just sized up its stake in an ALS-focused company heading into a pivotal year for the firm.

Via The Motley Fool

Topics Regulatory Compliance

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of commercialization.

Via The Motley Fool

Topics Regulatory Compliance

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

A science-first biotech fund is leaning deeper into one company just as its lead program delivers some compelling early neuro data.

Via The Motley Fool

Topics Regulatory Compliance

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

One biotech-focused investment firm cashed out of its stake in this drug developer as the stock soared—but seemingly missed out on a massive premium by mere weeks.

Via The Motley Fool

CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 14, 2025

From CG Oncology Inc.

Via GlobeNewswire

Why Cg Oncology Stock Rocketed 7% Higher Today ↗

October 08, 2025

One pundit believes this is a clinical-stage company well worth watching.

Via The Motley Fool

CG Oncology Stock Signals Bullish Momentum Ahead ↗

September 08, 2025

CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here's what to track...

Via Benzinga

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

September 05, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology Completes Enrollment in PIVOT-006

September 03, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences

August 29, 2025

From CG Oncology Inc.

Via GlobeNewswire

Cg Oncology (CGON) Q2 Loss Widens 93% ↗

August 08, 2025

Via The Motley Fool

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 08, 2025

From CG Oncology Inc.

Via GlobeNewswire

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

July 29, 2025

From CG Oncology Inc.

Via GlobeNewswire

Which stocks are moving before the opening bell on Tuesday? ↗

July 22, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock ↗

July 16, 2025

Via Benzinga

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

July 07, 2025

Via Investor Brand Network

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

July 07, 2025

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going

June 18, 2025

Issued on behalf of Oncolytics Biotech Inc. Vancouver, BC – June 18, 2025 – USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer....

Via FinancialNewsMedia

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

June 05, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

May 15, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

May 13, 2025

From CG Oncology Inc.

Via GlobeNewswire

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗

May 04, 2025

Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them?

Via Benzinga

Topics Artificial Intelligence

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

May 01, 2025

From CG Oncology Inc.

Via GlobeNewswire

These stocks are moving in today's session ↗

April 28, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.